Concepedia

Rumana Rafiq

RR

Statistics

Publications

13

Citations

2K

H-Index

13

Active since

2008

Affiliations

Breast Cancer Now(Current)

Institute of Cancer Research

UCSF Helen Diller Family Comprehensive Cancer Center

Cancer Research UK

University College Dublin

Rumana Rafiq is an author at Breast Cancer Now specializing in oncology, molecular oncology, and medicine.

Publications per year

2008–2019

13

Publications

13

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance

Stephen J. Pettitt, Dragomir B. Krastev, Inger Brandsma et al. · Nature Communications · 2018 · 447 citations · Full text

Medicine, Molecular Biology, Oncology +17

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A

Chris T. Williamson, Rowan Miller, Helen N. Pemberton et al. · Nature Communications · 2016 · 387 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity

Ilirjana Bajrami, Jessica Frankum, Asha Konde et al. · Cancer Research · 2013 · 368 citations · Full text

Medicine, Oncology, Pharmacology +17

Functional Viability Profiles of Breast Cancer

Rachel Brough, Jessica Frankum, David Sims et al. · Cancer Discovery · 2011 · 143 citations · Full text

Pharmacy, Molecular Biology, Oncology +15

E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

Ilirjana Bajrami, Rebecca Marlow, Marieke van de Ven et al. · Cancer Discovery · 2018 · 133 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 13